Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-03 Sale |
2020-06-05 4:59 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
12,798 | $74.19 | $949,431 | 141,734 (Direct) |
View |
| 2020-05-18 Sale |
2020-06-03 4:26 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
20,000 | $74.02 | $1,480,322 | 144,960 (Indirect Direct) |
View |
| 2020-05-26 Sale |
2020-05-27 3:14 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
260 | $74.93 | $19,482 | 18,331 (Direct) |
View |
| 2020-05-18 Sale |
2020-05-20 7:50 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
7,500 | $74.65 | $559,875 | 165,960 (Indirect Direct) |
View |
| 2020-05-18 Sale |
2020-05-20 7:49 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
29,113 | $73.33 | $2,134,885 | 138,242 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-19 7:15 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
2,461 | $71 | $174,731 | 34,524 (Direct) |
View |
| 2020-05-18 Sale |
2020-05-19 7:13 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
1,875 | $75 | $140,625 | 11,000 (Direct) |
View |
| 2020-05-18 Sale |
2020-05-19 7:12 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
2,722 | $74.72 | $203,374 | 27,312 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-26 Option Award |
2020-06-30 1:15 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director |
6,800 | $0 | 9,800 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:14 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
6,800 | $0 | 16,550 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:13 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director |
6,800 | $0 | 16,550 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:12 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,800 | $0 | 17,800 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:11 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Ekman Lars Director |
6,800 | $0 | 16,550 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:10 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
6,800 | $0 | 14,675 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:10 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
6,800 | $0 | 151,760 (Direct) |
View |
| 2020-06-19 Tax Withholding |
2020-06-22 1:47 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
303 | $78.22 | 23,850 (Direct) |
View |
| 2020-06-20 Tax Withholding |
2020-06-22 1:46 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
649 | $78.22 | 26,663 (Direct) |
View |
| 2020-06-03 Exercise |
2020-06-05 4:59 pm |
N/A 2028-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
12,798 | $0 | 141,734 (Direct) |
View |
| 2020-06-03 Exercise |
2020-06-05 4:59 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
12,798 | $48.43 | 141,734 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 2:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
262 | $69.38 | 34,961 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 2:20 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
262 | $69.38 | 49,341 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 2:19 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
348 | $69.38 | 101,208 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 2:18 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
348 | $69.38 | 101,740 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 2:17 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
1,334 | $69.38 | 3,070,782 (Direct) |
View |
| 2020-05-25 Tax Withholding |
2020-05-27 3:14 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
433 | $73.81 | 18,331 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-22 1:41 pm |
2019-06-19 2021-06-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Ultragenyx Pharmaceutical Inc. Director 10% Owner |
600,000 | $0 | 3,000,000 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-22 1:41 pm |
N/A N/A |
Arcturus Therapeutics Holdings Inc. | ARCT | Ultragenyx Pharmaceutical Inc. Director 10% Owner |
600,000 | $16 | 3,000,000 (Direct) |
View |
| 2020-05-18 Exercise |
2020-05-20 7:50 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
7,500 | $40.37 | 165,960 (Direct) |
View |
| 2020-05-18 Exercise |
2020-05-20 7:50 pm |
N/A 2024-07-10 |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
7,500 | $0 | 165,960 (Direct) |
View |
| 2020-05-18 Exercise |
2020-05-20 7:49 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
23,500 | $70.57 | 138,242 (Direct) |
View |
| 2020-05-18 Exercise |
2020-05-20 7:49 pm |
N/A 2026-06-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
26,721 | $0 | 138,242 (Direct) |
View |
| 2020-05-19 Exercise |
2020-05-20 7:49 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
3,221 | $48.43 | 138,242 (Direct) |
View |
| 2020-05-15 Exercise |
2020-05-19 7:15 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
1,500 | $21 | 34,524 (Direct) |
View |
| 2020-05-15 Exercise |
2020-05-19 7:15 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
1,500 | $0 | 34,524 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 8:12 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
249 | $66.26 | 36,051 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 8:11 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
209 | $66.26 | 24,153 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 8:10 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
248 | $66.26 | 34,979 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 8:08 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
138 | $66.26 | 19,680 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 8:06 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
852 | $66.26 | 3,212,538 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 8:04 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
248 | $66.26 | 101,675 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 8:02 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
248 | $66.26 | 29,904 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 7:56 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
248 | $66.26 | 48,991 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 7:55 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
248 | $66.26 | 103,336 (Direct) |
View |